Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 2 Device Recall AMPLATZER Delivery Systems

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
  Class 2 Device Recall AMPLATZER Delivery Systems see related information
Date Initiated by Firm November 23, 2004
Date Posted December 24, 2004
Recall Status1 Terminated 3 on December 26, 2006
Recall Number Z-0360-05
Recall Event ID 30481
Product Classification unknown device name - Product Code GBK
Product AMPLATZER Delivery System 180-degree curve, order no. 9-DEL-7F-180/80. Product is labeled as Sterile EO.
Amplatzer Occluder Device and Delivery System is comprised of delivery sheath, delivery cable, dilator, loading device and pin vise. The Delivery and Exchange Systems are placed onto polyboard backing cards. The backing card is then placed into a smaller of 2 Tyvek pouches. The pouch is then placed inside a larger Tyvek pouch. The kit is assembled at AGA and then sterilized by Steris, Minneapolis, MN.
Code Information 00L14-6, M01K28-17, M01L17-06, M02D16-18, M02D26-04,  M02I13-02, M02K07-04, M02K07-45, M02K12-11, M03A22-13,  M03C24-10, M03D02-06, M03D02-08, M03D16-17, M03G10-31,  M03G15-34, M03K24-14, M03L12-10, M03M12-19, M04B03-08,  M04B09-17, M04C01-18, M04D01-05, M04D06-11, M04D20-07,  M04E04-05, M04F08-21, M04H03-18, M04H24-25
Recalling Firm/
Manufacturer		 AGA Medical Corporation
682 Mendelssohn Ave N
Golden Valley MN 55427-4306
For Additional Information Contact Jody Raus
763-513-9227
Manufacturer Reason
for Recall		 Tubing utilized in the manufacture of the AMPLATZER Delivery and Exchange System sheaths and dilators was in some cases manufactured by our supplier outside of process parameters; causing a residue to be left on the inside of the tubing.
FDA Determined
Cause 2		 Other
Action Recall notices were sent via e-mail 11/22/04 to physicians, hospitals and distributors who received affected product. Hard copies of the Recall Notices were sent to all customers (international and domestic) via Federal Express 11/22-24/04. A form that is attached to the Recall Notice asks for customers to fill out quantities of affected product and to return the affected product to AGA Medical.
Quantity in Commerce 4979
Distribution Product has been distributed throughout the US and Internationally, including Canada, Europe and Australia.
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
-
-